Pediatric Thyroid Carcinoma: Incidence and Outcomes in 1753 Patients

Anthony Richard Hogan, Ying Zhuge, Eduardo Perez, Leonidas G. Koniaris, John Lew, Juan E Sola

Research output: Contribution to journalArticle

221 Citations (Scopus)

Abstract

Objective: To examine outcomes and predictors of survival for pediatric patients with thyroid carcinoma. Methods: The Surveillance, Epidemiology, and End Results (SEER) registry from 1973 to 2004 was queried for all patients with thyroid carcinoma less than 20 y of age. Results: A total of 1753 patients with malignant thyroid neoplasms were identified with an age-adjusted annual incidence of 0.54 cases per 100,000 persons. There has been a significant increase in the annual incidence by 1.1% per y. Female patients outnumbered males 4 to 1. Tumors were classified as papillary (n = 1044, 60%), follicular variant of papillary (n = 389, 23%), follicular (n = 165, 10%), and medullary (n = 87, 5%). The majority of patients presented with localized and regional disease. Overall mean survival time (MST) was 30.5 y. The MST for females was 40 y, whereas males survived an average of 20.4 y (P = 0.0001). Patients with medullary cancer had significantly shorter mean survival than those with papillary cancer (P = 0.006). Surgical treatment significantly improved outcome. Multivariate analysis demonstrated that male gender, nonpapillary histology, distant disease, and no surgery were all independent prognostic factors of worse outcome. For patients with medullary thyroid carcinoma, radiation therapy was also identified as an independent predictor of lower survival. Conclusion: The incidence of pediatric thyroid cancer is increasing. Females have a higher incidence than males, but enjoy longer survival. Papillary thyroid cancer has overall excellent survival. Male gender, nonpapillary tumor, distant metastases, and nonsurgical treatment all predict worse outcome.

Original languageEnglish
Pages (from-to)167-172
Number of pages6
JournalJournal of Surgical Research
Volume156
Issue number1
DOIs
StatePublished - Sep 1 2009

Fingerprint

Thyroid Neoplasms
Pediatrics
Incidence
Survival
Neoplasms
Survival Rate
Registries
Histology
Epidemiology
Radiotherapy
Multivariate Analysis
Neoplasm Metastasis
Therapeutics

ASJC Scopus subject areas

  • Surgery

Cite this

Pediatric Thyroid Carcinoma : Incidence and Outcomes in 1753 Patients. / Hogan, Anthony Richard; Zhuge, Ying; Perez, Eduardo; Koniaris, Leonidas G.; Lew, John; Sola, Juan E.

In: Journal of Surgical Research, Vol. 156, No. 1, 01.09.2009, p. 167-172.

Research output: Contribution to journalArticle

@article{1f34064feb30460e8032c776c8297fde,
title = "Pediatric Thyroid Carcinoma: Incidence and Outcomes in 1753 Patients",
abstract = "Objective: To examine outcomes and predictors of survival for pediatric patients with thyroid carcinoma. Methods: The Surveillance, Epidemiology, and End Results (SEER) registry from 1973 to 2004 was queried for all patients with thyroid carcinoma less than 20 y of age. Results: A total of 1753 patients with malignant thyroid neoplasms were identified with an age-adjusted annual incidence of 0.54 cases per 100,000 persons. There has been a significant increase in the annual incidence by 1.1{\%} per y. Female patients outnumbered males 4 to 1. Tumors were classified as papillary (n = 1044, 60{\%}), follicular variant of papillary (n = 389, 23{\%}), follicular (n = 165, 10{\%}), and medullary (n = 87, 5{\%}). The majority of patients presented with localized and regional disease. Overall mean survival time (MST) was 30.5 y. The MST for females was 40 y, whereas males survived an average of 20.4 y (P = 0.0001). Patients with medullary cancer had significantly shorter mean survival than those with papillary cancer (P = 0.006). Surgical treatment significantly improved outcome. Multivariate analysis demonstrated that male gender, nonpapillary histology, distant disease, and no surgery were all independent prognostic factors of worse outcome. For patients with medullary thyroid carcinoma, radiation therapy was also identified as an independent predictor of lower survival. Conclusion: The incidence of pediatric thyroid cancer is increasing. Females have a higher incidence than males, but enjoy longer survival. Papillary thyroid cancer has overall excellent survival. Male gender, nonpapillary tumor, distant metastases, and nonsurgical treatment all predict worse outcome.",
author = "Hogan, {Anthony Richard} and Ying Zhuge and Eduardo Perez and Koniaris, {Leonidas G.} and John Lew and Sola, {Juan E}",
year = "2009",
month = "9",
day = "1",
doi = "10.1016/j.jss.2009.03.098",
language = "English",
volume = "156",
pages = "167--172",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Pediatric Thyroid Carcinoma

T2 - Incidence and Outcomes in 1753 Patients

AU - Hogan, Anthony Richard

AU - Zhuge, Ying

AU - Perez, Eduardo

AU - Koniaris, Leonidas G.

AU - Lew, John

AU - Sola, Juan E

PY - 2009/9/1

Y1 - 2009/9/1

N2 - Objective: To examine outcomes and predictors of survival for pediatric patients with thyroid carcinoma. Methods: The Surveillance, Epidemiology, and End Results (SEER) registry from 1973 to 2004 was queried for all patients with thyroid carcinoma less than 20 y of age. Results: A total of 1753 patients with malignant thyroid neoplasms were identified with an age-adjusted annual incidence of 0.54 cases per 100,000 persons. There has been a significant increase in the annual incidence by 1.1% per y. Female patients outnumbered males 4 to 1. Tumors were classified as papillary (n = 1044, 60%), follicular variant of papillary (n = 389, 23%), follicular (n = 165, 10%), and medullary (n = 87, 5%). The majority of patients presented with localized and regional disease. Overall mean survival time (MST) was 30.5 y. The MST for females was 40 y, whereas males survived an average of 20.4 y (P = 0.0001). Patients with medullary cancer had significantly shorter mean survival than those with papillary cancer (P = 0.006). Surgical treatment significantly improved outcome. Multivariate analysis demonstrated that male gender, nonpapillary histology, distant disease, and no surgery were all independent prognostic factors of worse outcome. For patients with medullary thyroid carcinoma, radiation therapy was also identified as an independent predictor of lower survival. Conclusion: The incidence of pediatric thyroid cancer is increasing. Females have a higher incidence than males, but enjoy longer survival. Papillary thyroid cancer has overall excellent survival. Male gender, nonpapillary tumor, distant metastases, and nonsurgical treatment all predict worse outcome.

AB - Objective: To examine outcomes and predictors of survival for pediatric patients with thyroid carcinoma. Methods: The Surveillance, Epidemiology, and End Results (SEER) registry from 1973 to 2004 was queried for all patients with thyroid carcinoma less than 20 y of age. Results: A total of 1753 patients with malignant thyroid neoplasms were identified with an age-adjusted annual incidence of 0.54 cases per 100,000 persons. There has been a significant increase in the annual incidence by 1.1% per y. Female patients outnumbered males 4 to 1. Tumors were classified as papillary (n = 1044, 60%), follicular variant of papillary (n = 389, 23%), follicular (n = 165, 10%), and medullary (n = 87, 5%). The majority of patients presented with localized and regional disease. Overall mean survival time (MST) was 30.5 y. The MST for females was 40 y, whereas males survived an average of 20.4 y (P = 0.0001). Patients with medullary cancer had significantly shorter mean survival than those with papillary cancer (P = 0.006). Surgical treatment significantly improved outcome. Multivariate analysis demonstrated that male gender, nonpapillary histology, distant disease, and no surgery were all independent prognostic factors of worse outcome. For patients with medullary thyroid carcinoma, radiation therapy was also identified as an independent predictor of lower survival. Conclusion: The incidence of pediatric thyroid cancer is increasing. Females have a higher incidence than males, but enjoy longer survival. Papillary thyroid cancer has overall excellent survival. Male gender, nonpapillary tumor, distant metastases, and nonsurgical treatment all predict worse outcome.

UR - http://www.scopus.com/inward/record.url?scp=68649088275&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68649088275&partnerID=8YFLogxK

U2 - 10.1016/j.jss.2009.03.098

DO - 10.1016/j.jss.2009.03.098

M3 - Article

C2 - 19631341

AN - SCOPUS:68649088275

VL - 156

SP - 167

EP - 172

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 1

ER -